Author Profile

Destiny Hinton

Destiny HInton

Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.

Stories by Destiny Hinton

St. Jude On

Genomic instability is a risk for neurological disease and an opportunity for intervention

Alex Generous, PhD

Fixing DNA damage repair systems to help patients.

Outreach

Finding your footing for a future in biomedical research

LaToyia P. Downs, PhD

St. Jude is preparing future scientists through education, training pathways and STEMM initiatives, inspiring careers in biomedical research and healthcare.

St. Jude On

Biomolecular organization holds tantalizing clues for neurological disease treatment

Brian O'Flynn, PhD

 See how microscopic “bubbles” set the stage for neurological breakthroughs

Research

Protein Production Facility accelerates research

Paige Brown Jarreau, PhD

Scientists at the Protein Production Facility are making high quality proteins to help support research across St. Jude.

Investigator Insights

5 Questions for Lisett Contreras, PhD

Erin Podolak, MA and Lisett Contreras, PhD

Meet postdoctoral researcher Lisett Contreras, PhD, Department of Pathology, and learn about her research.  

Research

Laying the foundation for neuronal development

Brian O'Flynn, PhD

See how blocking one kinase resulted in premature neuron growth

Investigator Insights

5 Questions for Renato Umeton, PhD

Renato Umeton, PhD and Alex Generous, PhD

Meet St. Jude Chief of AI Renato Umeton, PhD, Office of Data Science.

Outreach

Working globally to save critically ill children with cancer

LaToyia P. Downs, PhD

The Global Critical Care Program is advancing critical care for children with cancer worldwide through innovation, collaboration and education.

Investigator Insights

5 Questions for Anand Kulkarni, PhD

Erin Podolak, MA and Anand Kulkarni, PhD

Learn what associate scientist Anand Kulkarni, PhD, thinks makes doing research at St. Jude different from anywhere else.

Clinical

Research findings set the stage for GLOBOTRK, a clinical trial with targeted therapy for NTRK and ROS1 fusions

Alex Generous, PhD

St. Jude is leading a global clinical trial for brain tumors.